Workflow
Nevro(NVRO)
icon
Search documents
Nevro(NVRO) - 2022 Q1 - Earnings Call Presentation
2022-05-06 02:20
1Q 2022 Earnings Presentation M A Y 4 , 2 0 2 2 Dania Forward-Looking Statements In addition to historical information, this presentation contains forward-looking statements reflecting the company's current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including: our second quarter and full-year 2022 financial guidance, including our expectations for PDN revenue in 2022; our expectations that the recent positive up ...
Nevro(NVRO) - 2022 Q1 - Quarterly Report
2022-05-04 20:47
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-36715 Nevro Corp. (Exact name of registrant as specified in its charter) Delaware 56-2568057 (State or other jurisdiction of incorporation or organization) (I.R. ...
Nevro(NVRO) - 2021 Q4 - Earnings Call Presentation
2022-02-24 00:45
| --- | --- | --- | --- | --- | --- | --- | |-----------------------------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | 4Q and Full-Year | | | | | | | | | | | | | | | | 2021 Earnings | | | | | | | | Presentation | | | | | | | | F E B R UA RY 2 3 , 2 0 2 2 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Forward-Looking Statements In addition to historical information, this presentation contains forward-looking statements reflecting the compa ...
Nevro(NVRO) - 2021 Q4 - Earnings Call Transcript
2022-02-24 00:42
Nevro Corp. (NYSE:NVRO) Q4 2021 Earnings Conference Call February 23, 2022 4:30 PM ET Company Participants Julie Dewey - Corporate Communications and Investor Relations Officer Keith Grossman - Chairman, Chief Executive Officer and President Rod MacLeod - Chief Financial Officer Conference Call Participants Chris Pasquale - Guggenheim Adam Maeder - Piper Sandler David Rescott - Truist Security Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Ti ...
Nevro(NVRO) - 2021 Q4 - Annual Report
2022-02-23 21:53
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2021 or ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 001-36715 NEVRO CORP. (Exact name of registrant as specified in its charter) Delaware 56-2568057 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Iden ...
Nevro (NVRO) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference
2022-01-24 19:21
| --- | --- | --- | --- | --- | |------------------------------------------------------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | From Recovery to | | | | | | Renewed Growth | | | | | | J.P. Morgan 40 th Annual Healthcare Conference | | | | | | D . K E I T H G R O S S M A N CHAIRMAN, CEO & PRESIDENT J A N UA RY 1 0 , 2 0 2 2 | | | | | | | | | | | | | | | | | | | | | | | Forward-Looking Statements | --- | --- | --- | --- | --- | |-------------------------------- ...
Nevro(NVRO) - 2021 Q3 - Earnings Call Presentation
2021-11-10 19:36
IIIIIII nevro 3Q 2021 Earnings Presentation November 8, 2021 Forward-looking Statements In addition to historical information, this presentation contains forward-looking statements reflecting the company's current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including: our fourth quarter financial guidance; our belief that there is a significant opportunity to offer our innovative therapy to PDN patients who are u ...
Nevro(NVRO) - 2021 Q3 - Earnings Call Transcript
2021-11-09 04:53
Nevro Corp. (NYSE:NVRO) Q3 2021 Earnings Conference Call November 8, 2021 4:30 PM ET Company Participants Julie Dewey - Vice President-Investor Relations and Corporate Communications Keith Grossman - Chairman, Chief Executive Officer and President Rod MacLeod - Chief Financial Officer Conference Call Participants Joanne Wuensch - Citi Chris Pasquale - Guggenheim Tom Hopkins - Bank of America Robbie Marcus - JPMorgan Matt Taylor - UBS Daniel Antalffy - SVB Leerink David Rescott - Truist Security Suraj Kalia ...
Nevro(NVRO) - 2021 Q3 - Quarterly Report
2021-11-08 21:52
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-36715 Nevro Corp. (Exact name of registrant as specified in its charter) Delaware 56-2568057 (State or other jurisdiction of incorporation or organization) ( ...
Nevro(NVRO) - 2021 Q2 - Earnings Call Presentation
2021-08-05 14:40
IIIIIIII nevro 2Q 2021 Earnings Presentation August 4, 2021 Forward-looking Statements In addition to historical information, this presentation contains forward-looking statements reflecting the company's current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including: our third quarter financial guidance; our belief that there is a significant opportunity to offer our innovative therapy to PDN patients who are una ...